Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481052
Status:
COMPLETED
Last Update Posted:
2022-01-18
First Post:
2007-05-31
Brief Title:
Nilotinib as First-line Treatment of Ph CML in Early Chronic Phase
Sponsor:
Gruppo Italiano Malattie EMatologiche dellAdulto
Organization:
Gruppo Italiano Malattie EMatologiche dellAdulto